Generate a tailored SOP for Dr. Caroline Hendry. Improve your application with a focused, well-structured draft.
Caroline Hendry serves as the Scientific Director and Advisor Chair in Genetics at Yale School of Medicine. In her role as Director of the Office of Strategic Research Development, she is responsible for increasing research innovation and discovery through strategic portfolio planning and advisory collaboration. Caroline leads initiatives in high-growth areas such as rare disease research and population/preventative health screening, focusing on IND-enabling R&D in gene and cell-based therapies. She plays a key role in establishing efficient operational processes for basic and clinical research. Originally from Brisbane, Australia, Caroline earned her undergraduate degree in Genetics from the University of Queensland before completing her PhD in developmental genetics at the Institute for Molecular Bioscience. She furthered her training with a postdoctoral position at Mount Sinai School of Medicine, specializing in molecular reprogramming. After her postdoc, she took on the role of Reviews Editor for the journal 'Development', where she covered topics in stem cells and regeneration. Recruited to Yale in 2018, Caroline has co-investigated several large NIH grants in the clinical-translational space. Aside from her scientific training, she possesses extensive experience in project management and research administration. Currently, she is pursuing an MBA at Yale School of Management with a focus on the healthcare sector.
GRE is optional for PhD applicants. TOEFL speaking scores below 26 or IELTS speaking below 7.5 may require summer English training.